Risperidone versus haloperidol for facial affect recognition in schizophrenia: Findings from a randomised study

World Journal of Biological Psychiatry

Volumn 10, Issue 4 PART 3, 2009, Pages 719-728

  Fakra, Eric ^a,b   Salgado Pineda, Pilar ^b   Besnier, Nathalie ^a   Azorin, Jean Michel ^a   Blin, Olivier ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Medicine University   (France)

Author keywords

Antipsychotics; Atypical antipsychotics; Negative symptoms; Prospective study; Schizophrenia

Indexed keywords

HALOPERIDOL; RISPERIDONE; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFECT; FACIES; FEMALE; HUMAN; MALE; PERCEPTIVE DISCRIMINATION; RECOGNITION; SCHIZOPHRENIA; SEMANTICS; ACUTE DISEASE; ADOLESCENT; AFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FACIAL EXPRESSION; HOSPITALIZATION; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AFFECT; ANTIPSYCHOTIC AGENTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FACIAL EXPRESSION; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOGNITION (PSYCHOLOGY); RISPERIDONE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77949502709     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701432536     Document Type: Article

References (66)

1. Addington J, Addington D. 1998. Facial affect recognition and information processing in schizophrenia and bipolar disorder. Schizophr Res 32:171-181.
2. Baudouin JY, Martin F, Tiberghien G, Verlut I, Franck N. 2002. Selective attention to facial emotion and identity in schizophrenia. Neuropsychologia 40:503-511.
3. Borod JC, Martin CC, Alpert M, Brozgold A, Welkowitz J. 1993. Perception of facial emotion in schizophrenic and right braindamaged patients. J Nerv Ment Dis 181:494-502.
4. Breier A. 1995. Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res 14:187-202.
5. Bryson G, Bell M, Lysaker P. 1997. Affect recognition in schizophrenia: a function of global impairment or a specific cognitive deficit. Psychiatry Res 71:105-113.
6. Bryson G, Bell M, Kaplan E, Greig T, Lysaker P. 1998. Affect recognition in deficit syndrome schizophrenia. Psychiatry Res 77:113-120.
7. Chouinard G, Ross-Chouinard A, Annable L, Jones B. 1980. The extrapyramidal symptom rating scale. Can J Neurol Sci 7:233.
8. Corbett R, Hartman H, Kerman LL, et al. 1993. Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacol Biochem Behav 45:9-17.
9. Davis PJ, Gibson MG. 2000. Recognition of posed and genuine facial expressions of emotion in paranoid and nonparanoid schizophrenia. J Abnorm Psychol 109:445-450.
10. Delaveau P, Salgado-Pineda P, Wicker B, Micallef-Roll J, Blin O. 2005. Effect of levodopa on healthy volunteers' facial emotion perception: an FMRI study. Clin Neuropharmacol 28:255-261.
11. Edwards J, Pattison PE, Jackson HJ, Wales RJ. 2001. Facial affect and affective prosody recognition in first-episode schizophrenia. Schizophr Res 48:235-253
12. Edwards J, Jackson HJ, Pattison PE. 2002. Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review. Clin Psychol Rev 22:789-832.
13. Ekman P, Friesen WV. 1976. Pictures of facial affect. Palo Alto, CA: C.P. Press.
14. Epstein RA, Higgins JS, Parker W, Aguirre GK, Cooperman S. 2006. Cortical correlates of face and scene inversion: a comparison. Neuropsychologia 44:1145-1158.
15. Feinberg TE, Rifkin A, Schaffer C, Walker E. 1986. Facial discrimination and emotional recognition in schizophrenia and affective disorders. Arch Gen Psychiatry 43:276-279.
16. First MB, Spitzer RL, Gibbon M, Williams JBW 1997a. Structured Clinical Interview for DSM-IV Axis 1 Disorders-Clinical Version (SCID-CV). Washington, DC: American Psychiatric Press.
17. First MB, Spitzer RL, Williams JBW, Gibbon M. 1997b. User's Guide for the Structured Clinical Interview for DSM-IV Axis 1 Disorders-Clinical Version (SCID-CV). Washington, DC: American Psychiatric Press.
18. Gaebel W, Wolwer W 1992. Facial expression and emotional face recognition in schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci 242:46-52.
19. George MS, Ketter TA, Gill DS, et al. 1993. Brain regions involved in recognizing facial emotion or identity: an oxygen-15 PET study. J Neuropsychiatry Clin Neurosci 5:384-394.
20. Gooding DC, Tallent KA. 2002. Schizophrenia patients' perceptual biases in response to positively and negatively valenced emotion chimeras. Psychol Med 32:1101-1107.
21. Gooding DC, Luh KE, Tallent KA. 2001. Evidence of schizophrenia patients' reduced perceptual biases in response to emotion chimera. Schizophr Bull 27:709-716.
22. Green MF, Nuechterlein KH. 1999. Should schizophrenia be treated as a neurocognitive disorder? Schizophr Bull 25:309-319.
23. Gur RE, Loughead J, Kohler C, Elliot M, Lesko K, Gur RC. 2007. Neural correlates of emotion processing in schizophrenia. Schizophr Bull 33:369.
24. Hariri AR, Drabant EM, Munoz KE, et al. 2005. A susceptibility gene for affective disorders and the response of the human amygdala. Arch Gen Psychiatry 62:146-152.
25. Harmer CJ, Bhagwagar Z, Perrett DI, Vollm BA, Cowen PJ, Goodwin GM. 2003. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsycho-pharmacology 28:148-152.
26. Harvey PD, Rabinowitz J, Eerdekens M, Davidson M. 2005. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry 162:1888-1895.
27. Herbener ES, Hill SK, Marvin RW, Sweeney JA. 2005. Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia. Am J Psychiatry 162:1746-1748.
28. Hooker C, Park S. 2002. Emotion processing and its relationship to social functioning in schizophrenia patients. Psychiatry Res 112:41-50.
29. Insel TR, Fernald RD. 2004. How the brain processes social information: searching for the social brain. Annu Rev Neurosci 27:697-722.
30. Kasper S, Tauscher J, Kufferle B, Barnas C, Pezawas L, Quiner S. 1999. Dopamine-and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia. Eur Arch Psychiatry Clin Neurosci 249(Suppl 4):83-89.
31. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276.
32. Kee KS, Kern RS, Marshall BD Jr, Green MF. 1998. Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings. Schizophr Res 31:159-165.
33. Kee KS, Green MF, Mintz J, Brekke JS. 2003. Is emotion processing a predictor of functional outcome in schizophrenia? Schizophr Bull 29:487-497.
34. Kee KS, Horan WP, Mintz J, Green MF. 2004. Do the siblings of schizophrenia patients demonstrate affect perception deficits? Schizophr Res 67:87-94.
35. Keefe RS, Young CA, Rock SL, Purdon SE, Gold JM, Breier A. 2006. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophr Res 81:1-15.
36. Kerr SL, Neale JM. 1993. Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance? J Abnorm Psychol 102:312-318.
37. Kohler CG, Bilker W, Hagendoorn M, Gur RE, Gur RC. 2000. Emotion recognition deficit in schizophrenia: association with symptomatology and cognition. Biol Psychiatry 48:127-136.
38. Kosmidis MH, Bozikas VP, Giannakou M, Anezoulaki D, Fantie BD, Karavatos A. 2006. Impaired emotion perception in schizophrenia: A differential deficit. Psychiatry Res.
39. Lewis SF, Garver DL. 1995. Treatment and diagnostic subtype in facial affect recognition in schizophrenia. J Psychiatr Res 29:5-11.
40. Loughland CM, Williams LM, Gordon E. 2002. Visual scanpaths to positive and negative facial emotions in an outpatient schizophrenia sample. Schizophr Res 55:159-170.
41. Mandal MK, Pandey R, Prasad AB. 1998. Facial expressions of emotions and schizophrenia: a review. Schizophr Bull 24:399-412.
42. Mandal MK, Jain A, Haque-Nizamie S, Weiss U, Schneider F. 1999. Generality and specificity of emotion-recognition deficit in schizophrenic patients with positive and negative symptoms. Psychiatry Res 87:39-46
43. Martin F, Baudouin JY, Tiberghien G, Franck N. 2005. Processing emotional expression and facial identity in schizophrenia. Psychiatry Res 134:43-53. (Pubitemid 40460972)
44. McGurk SR, Green MF, Wirshing WC, et al. 2004. Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res 68:225-233.
45. Mueser KT, Doonan R, Penn DL, et al. 1996. Emotion recognition and social competence in chronic schizophrenia. J Abnorm Psychol 105:271-275.
46. Phillips ML, David AS. 1997. Visual scan paths are abnormal in deluded schizophrenics. Neuropsychologia 35:99-105.
47. Nyberg S, Nakashima Y, Nordstrom AL, Halldin C, Farde L. 1996. Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response. Br J Psychiatry Suppl:40-44.
48. Phillips ML, Drevets WC, Rauch SL, Lane R. 2003a. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry 54:504-514. (Pubitemid 37289437)
49. Phillips ML, Drevets WC, Rauch SL, Lane R. 2003b. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 54:515-528.
50. Poole JH, Tobias FC, Vinogradov S. 2000. The functional relevance of affect recognition errors in schizophrenia. J Int Neuropsychol Soc 6:649-658.
51. Reynolds GP. 1983. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305:527-529.
52. Sachs G, Steger-Wuchse D, Kryspin-Exner I, Gur RC, Katschnig H. 2004. Facial recognition deficits and cognition in schizophrenia. Schizophr Res 68:27-35.
53. Salem JE, Kring AM, Kerr SL. 1996. More evidence for generalized poor performance in facial emotion perception in schizophrenia. J Abnorm Psychol 105:480-483
54. Salgado-Pineda P, Delaveau P, Blin O, Nieoullon A. 2005. Dopaminergic contribution to the regulation of emotional perception. Clin Neuropharmacol 28:228-237.
55. Schneider F, Gur RC, Gur RE, Shtasel DL. 1995. Emotional processing in schizophrenia: neurobehavioral probes in relation to psychopathology. Schizophr Res 17:67-75.
56. Schneider F, Gur RC, Koch K, Backes V, Amunts K, Shah NJ, et al. 2006. Impairment in the specificity of emotion processing in schizophrenia. Am J Psychiatry 163:442-447.
57. Schwartz BL, Marvel CL, Drapalski A, Rosse RB, Deutsch SI. 2002. Configural processing in face recognition in schizophrenia. Cognit Neuropsychiatry 7:15-39.
58. Streit M, Wolwer W, Gaebel W. 1997. Facial-affect recognition and visual scanning behaviour in the course of schizophrenia. Schizophr Res 24:311-317.
59. Streit M, Ioannides A, Sinnemann T, Wolwer W, Dammers J, Zilles K, et al. 2001. Disturbed facial affect recognition in patients with schizophrenia associated with hypoactivity in distributed brain regions: a magnetoencephalographic study. Am J Psychiatry 158:1429-1436.
60. Toomey R, Seidman LJ, Lyons MJ, Faraone SV, Tsuang MT. 1999. Poor perception of nonverbal social-emotional cues in relatives of schizophrenic patients. Schizophr Res 40:121-130.
61. Walker E, McGuire M, Bettes B. 1984. Recognition and identification of facial stimuli by schizophrenics and patients with affective disorders. Br J Clin Psychol 23(Pt 1):37-44.
62. Whittaker JF, Deakin JF, Tomenson B. 2001. Face processing in schizophrenia: defining the deficit. Psychol Med 31:499-507.
63. Williams LM, Loughland CM, Green MJ, Harris AW, Gordon E. 2003. Emotion perception in schizophrenia: an eye movement study comparing the effectiveness of risperidone vs. haloper-idol. Psychiatry Res 120:13-27.
64. Wolwer W, Frommann N, Halfmann S, Piaszek A, Streit M, Gaebel W 2005. Remediation of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program. Schizophr Res 80:295-303.
65. Woods SW 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64:663-667.
66. Woodward ND, Purdon SE, Meltzer HY, Zald DH. 2005. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 8:457-472